PCVII COST EFFECTIVENESS OF ADDING NIASPANTO ATORVASTATIN TREATMENT IN THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH DYSLIPIDEMIA IN THE UK
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65793-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65793-2/fulltext
Title :
PCVII COST EFFECTIVENESS OF ADDING NIASPANTO ATORVASTATIN TREATMENT IN THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH DYSLIPIDEMIA IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65793-2&doi=10.1016/S1098-3015(10)65793-2
First page :
Section Title :
Open access? :
No
Section Order :
160